Literature DB >> 11964576

Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques.

Gerard E Francisco1, Corwin Boake, Amy Vaughn.   

Abstract

OBJECTIVE: To compare the efficacy of two different volume preparations of the same dose of botulinum toxin-A in relieving spasticity in wrist and finger flexors secondary to acquired brain injury.
DESIGN: Thirteen adult patients who had modified Ashworth scale scores of 3 for both wrist and finger flexors were included in this randomized, controlled trial. Wrist and finger flexors were each injected. Blinded modified Ashworth scale ratings of wrist and finger flexor spasticity were measured.
RESULTS: Spasticity in both muscles decreased significantly in both treatment groups. However, the high-volume and low-volume groups did not differ significantly in spasticity reduction.
CONCLUSIONS: Because this preliminary study found no difference in spasticity reduction between high- and low-volume preparations of a 60-unit dose of botulinum toxin-A, a larger-sample study seems warranted to compare the efficacy of high-volume and low-volume preparations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964576     DOI: 10.1097/00002060-200205000-00007

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  13 in total

1.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Authors:  A S Schroeder; S Berweck; S H Lee; F Heinen
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb.

Authors:  Guy Molenaers; Anja Van Campenhout; Katrien Fagard; Jos De Cat; Kaat Desloovere
Journal:  J Child Orthop       Date:  2010-03-18       Impact factor: 1.548

4.  Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections.

Authors:  M Kristi Henzel; Michael C Munin; Christian Niyonkuru; Elizabeth R Skidmore; Douglas J Weber; Ross D Zafonte
Journal:  PM R       Date:  2010-07       Impact factor: 2.298

5.  Systematic test of neurotoxin dose and volume on muscle function in a rat model.

Authors:  Jonah B Hulst; Viviane B Minamoto; Michael B Lim; Shannon N Bremner; Samuel R Ward; Richard L Lieber
Journal:  Muscle Nerve       Date:  2014-01-28       Impact factor: 3.217

Review 6.  Botulinum toxin in poststroke spasticity.

Authors:  Suheda Ozcakir; Koncuy Sivrioglu
Journal:  Clin Med Res       Date:  2007-06

7.  Surface mapping of motor points in biceps brachii muscle.

Authors:  Ja-Young Moon; Tae-Sun Hwang; Seon-Ju Sim; Sae-Il Chun; Minyoung Kim
Journal:  Ann Rehabil Med       Date:  2012-04-30

Review 8.  OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review.

Authors:  Luba Nalysnyk; Spyridon Papapetropoulos; Philip Rotella; Jason C Simeone; Katharine E Alter; Alberto Esquenazi
Journal:  BMC Neurol       Date:  2013-09-08       Impact factor: 2.474

9.  Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: A placebo-controlled, blinded, randomized trial.

Authors:  Helka M Heikkilä; Tarja S Jokinen; Pernilla Syrjä; Jouni Junnila; Anna Hielm-Björkman; Outi Laitinen-Vapaavuori
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

10.  Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience.

Authors:  Alberto Esquenazi; Stella Lee; Nathaniel Mayer; Roser Garreta; Atul Patel; Elie Elovic; Stephen Koelbel; Gerard Francisco; Iris Reuter
Journal:  Am J Phys Med Rehabil       Date:  2017-12       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.